Advances in Tumor Angiogenesis
(2016)
Advances in Tumor Angiogenesis: pp.
-.
Chapter 11
Lenvatinib, an Angiogenesis Inhibitor Targeting VEGFR/FGFR, Shows Broad Antitumor Activity in Human Tumor Xenograft Models Associated with Microvessel Density and Pericyte Coverage